Windlas Biotech Limited (WINDLAS)
₹891
INR-1.30(-0.15%)
As of June 30, 2025 9:35:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1870.20 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1663.00 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
30.86
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.46
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
38.24%
Operating Margin
Operating income as a percentage of revenue
10.67%
Return on Equity
Net income as a percentage of shareholders' equity
12.76%
Revenue (TTM)
Total revenue over trailing 12 months
₹759.88 Cr+21.2%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹112.13 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹28.91-4.2%
Balance Sheet
Total Cash
Total cash and short-term investments
₹239.30 Cr
Total Debt
Total short-term and long-term debt
₹32.60 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
6.45%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹659 - ₹1198.25
Beta
Measure of stock's volatility compared to the market
0.31
Shares Outstanding
Total number of shares issued by the company
₹2.10 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
2.47%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.62%
Payout Ratio
Percentage of earnings paid as dividends
19.05%
